Improving Primary Care After Stroke: A randomised controlled trial

  • Research type

    Research Study

  • Full title

    Improving Primary Care After Stroke (IPCAS): A randomised controlled trial to evaluate a new model of care for stroke survivors living in the community.

  • IRAS ID

    233891

  • Contact name

    Jonathan Mant

  • Contact email

    jm677@medschl.cam.ac.uk

  • Sponsor organisation

    University of Cambridge

  • Clinicaltrials.gov Identifier

    NCT03353519

  • Duration of Study in the UK

    2 years, 4 months, days

  • Research summary

    Background: No formal primary care based model of care exists to support stroke survivors living in the community. A large variation in the range, quality and access to health services offered to stroke survivors between and within clinical commissioning groups suggests that many of the stroke survivors’ needs are not being met systematically. Therefore, to address the longer term needs we have developed a multi-factorial primary care model that seeks to enable greater engagement with stroke care and community services, to link effectively to specialist services, and to improve the lives of stroke survivors. Specifically, the intervention will comprise the following components: 1) a structured review of patient needs; 2) a self-management programme (MLAS) for stroke survivors and their carers; 3) a direct point of contact for stroke survivors and carers at the GP surgery; 4) enhanced communication pathways between General Practice staff and specialist services; 5) service mapping for stroke related needs; and 6) training for General Practice staff.

    Aim: To determine whether the novel model of primary care provides better long-term care for stroke survivors living in the community than current clinical practice. We will consider both clinical and cost outcomes.

    Method: The IPCAS Trial is a two-arm randomised controlled trial. General practices will be randomised to deliver either the new model of care, or usual clinical care. People with a history of stroke registered with GP practices in the East of England and the East Midlands will be invited to take part. We will aim to recruit 920 people from approximately 46 general practices.

    Analysis: The primary outcome for the trial will be measured using two sub-scales (emotion and handicap) of the Stroke Impact Scale questionnaire at 12 months.

  • REC name

    Yorkshire & The Humber - Bradford Leeds Research Ethics Committee

  • REC reference

    17/YH/0441

  • Date of REC Opinion

    19 Dec 2017

  • REC opinion

    Favourable Opinion